Skip to main content
. 2019 Oct 30;3(4):1–7. doi: 10.1093/ehjcr/ytz188

Table 1.

Patient 1’s serial fluorodeoxyglucose–positron emission tomography scans

Scan number Months post-initial scan Immunosuppressant SUV LVEF (%) MBF (mL/g/min) % Scarring
1 (initial) 0 9.9 35 1.12 0%
2 12 Methotrexate 52 1.08 0%
3 20 4.2 48 0.91 0%
4 26 20 mg prednisone 54 1.05 0%